Form 8-K · Current report
Cardinal Health 8-K, filed Nov 5, 2026
- Filed
- CIK
- 0000721371
- Accession no.
- 0000721371-26-000042
Summary
Cardinal Health's first-quarter fiscal 2027 revenue rose 5% to $67.5 billion, with GAAP diluted EPS up 27% to $2.38 and non-GAAP diluted EPS up 28% to $3.26, and the company raised its fiscal 2027 non-GAAP EPS guidance to $12.80–$13.00. CEO Jason Hollar said the results reflected a strong start and focused investments, disciplined operations, and a diversified portfolio.
Key points
- Q1 FY27 GAAP operating earnings increased 13% to $753 million, and non-GAAP operating earnings increased 17% to $1.0 billion.
- Cardinal Health raised FY27 non-GAAP diluted EPS guidance to $12.80–$13.00 from $12.40–$12.60.
- The company completed a $500 million share repurchase program in Q1 and entered a binding letter of intent to renew pharmaceutical distribution agreements with CVS Health.
- Cardinal Health anticipates completing the acquisition of AdaptHealth's Diabetes Health business in Q3 FY27 and launched the INSIGHT-IBD real-world evidence study with Eli Lilly.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02: Results of Operations and Financial Condition On November 5, 2026, Cardinal Health, Inc. (the "Company") issued a news release announcing its results for the quarter ended September 30, 2026. A copy of the news release is included as Exhibit 99.1 to this report. Item 7.01: Regulation FD Disclosure During a webcast scheduled to be held at 8:30 a.m. Eastern time on November 5, 2026, the Company's Chief Executive Officer and Chief Financial Officer will discuss the Company's results for the quarter ended September 30, 2026 and outlook for the fiscal year ending June 30, 2027. The slide presentation for the webcast will be available on the Investors page at ir.cardinalhealth.com. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.